AXIM Assays Headed Into 40 Clinics

DIAGNOSTICS: Business Targets Dry Eye Disease, Brings COO on Board

■ By BRAD GRAVES
SDBJ INSIDER

Dry Eye Disease, also known as DED, is a condition that can be difficult to diagnose. Mira Mesa-based AXIM Biotechnologies (OTBQB: AXIM) is working to put it in a better light. Late last month (May 24), AXIM announced the launch of its diagnostic...

Read latest San Diego Business Journal online.

Online newspapers at PressDisplay.